Hims & Hers Health Inc Ordinary Shares - Class A HIMS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
-
Shares of Hims & Hers, known for hair-loss treatments and Viagra, rally amid market panic
-
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
-
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
-
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
-
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
-
Hims & Hers shares rally as forecast bumped higher and more profitability said to be ahead
-
Hims & Hers' stock jumps on hopes of a first profitable year, as it floats opportunities in weight loss
Trading Information
- Previous Close Price
- $17.77
- Day Range
- $17.61–18.65
- 52-Week Range
- $5.65–25.74
- Bid/Ask
- $18.42 / $18.56
- Market Cap
- $3.99 Bil
- Volume/Avg
- 6.9 Mil / 8.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 191.97
- Price/Sales
- 3.69
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.05%
Company Profile
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,046
- Website
- https://www.forhims.com
Comparables
Valuation
|
Metric
|
HIMS
|
AGL
|
PRVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 191.97 | — | 25.82 |
Price/Book Value | 10.64 | 2.27 | 3.63 |
Price/Sales | 3.69 | 0.30 | 1.33 |
Price/Cash Flow | 36.63 | — | 28.28 |
Price/Earnings
HIMS
AGL
PRVA
Financial Strength
|
Metric
|
HIMS
|
AGL
|
PRVA
|
|---|---|---|---|
Quick Ratio | 2.14 | 1.32 | 1.76 |
Current Ratio | 2.68 | 1.36 | 1.81 |
Interest Coverage | — | −32.76 | — |
Quick Ratio
HIMS
AGL
PRVA
Profitability
|
Metric
|
HIMS
|
AGL
|
PRVA
|
|---|---|---|---|
Return on Assets (Normalized) | 19.60% | −7.62% | 8.68% |
Return on Equity (Normalized) | 25.08% | −21.88% | 15.60% |
Return on Invested Capital (Normalized) | 24.46% | −19.92% | 12.98% |
Return on Assets
HIMS
AGL
PRVA
Household & Personal Products Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Procter & Gamble Co
PG
| Mfdzddjbt | Nbjp | $407.8 Bil | |||
| Unilever PLC ADR
UL
| Rmdjnqz | Wmb | $163.1 Bil | |||
| Colgate-Palmolive Co
CL
| Gwtpqzyg | Rbqc | $84.7 Bil | |||
| Kimberly-Clark Corp
KMB
| Rtdycwwls | Yftbmh | $48.0 Bil | |||
| Kenvue Inc
KVUE
| Lnjmfcdq | Kxnq | $44.5 Bil | |||
| Reckitt Benckiser Group PLC ADR
RBGLY
| Ksqkkyvg | Vfb | $43.6 Bil | |||
| The Estee Lauder Companies Inc Class A
EL
| Zfjvvbq | Ghfyx | $35.9 Bil | |||
| Church & Dwight Co Inc
CHD
| Psyykjxjg | Fxlqq | $25.6 Bil | |||
| Clorox Co
CLX
| Whpydcrsn | Mnhk | $20.2 Bil | |||
| Coty Inc Class A
COTY
| Ypq | Lbjf | $8.3 Bil |
United States